Endocrinology & Nutrition Department, Instituto de Investigación Biomédica Ramón y Cajal (IRYCIS), Hospital Universitario Ramón y Cajal, Madrid.
University of Alcalá.
J Hypertens. 2024 Feb 1;42(2):252-259. doi: 10.1097/HJH.0000000000003596. Epub 2023 Oct 10.
To identify presurgical and surgical risk factors for intraoperative hypertensive crisis in patients with pheochromocytomas and sympathetic paragangliomas (PGLs) (PPGLs).
Retrospective multicenter cohort study of patients with PPGLs from 18 tertiary hospitals. Intraoperative hypertensive crisis was defined as systolic blood pressure (SBP) greater than 200 mmHg lasting more than 1 min and postoperative hypertensive crisis as SBP greater than 180 mmHg or diastolic blood pressure (DBP) greater than 110 mmHg.
A total of 296 surgeries were included. Alpha presurgical blockade was employed in 93.2% of the cases and beta-adrenergic in 53.4%. Hypertensive crisis occurred in 20.3% ( n = 60) of the surgeries: intraoperative crisis in 56 and postoperative crisis in 6 cases (2 cases had both types of crises). We identified as risk factors of intraoperative hypertensive crisis, absence of presurgical glucocorticoid therapy (odds ratio [OR] 3.48; 95% confidence interval [CI] 1.19-10.12) higher presurgical SBP (OR 1.22 per each 10 mmHg, 95% CI 1.03-1.45), a larger tumor size (OR 1.09 per each 10 mm, 95% CI 1.00-1.19) and absence of oral sodium repletion (OR 2.59, 95% CI 1.25-5.35). Patients with hypertensive crisis had a higher rate of intraoperative bleeding ( P < 0.001), of intraoperative hemodynamic instability ( P < 0.001) and of intraoperative hypotensive episodes ( P < 0.001) than those without hypertensive crisis.
Intraoperative hypertensive crisis occurs in up to 20% of the PPGL resections. Patients not pretreated with glucocorticoid therapy before surgery, with larger tumors and higher presurgical SBP and who do not receive oral sodium repletion have a higher risk for developing hypertensive crisis during and after PPGL surgery.
确定嗜铬细胞瘤和交感神经副神经节瘤(PPGLs)患者围手术期发生术中高血压危象的术前和手术风险因素。
回顾性分析了来自 18 家三级医院的 296 例 PPGL 患者的多中心队列研究。术中高血压危象定义为收缩压(SBP)大于 200mmHg 持续超过 1 分钟,术后高血压危象定义为 SBP 大于 180mmHg 或舒张压(DBP)大于 110mmHg。
共进行了 296 例手术。93.2%的病例采用了α受体阻滞剂术前阻断,53.4%采用了β肾上腺素能受体阻滞剂。20.3%(n=60)的手术发生了高血压危象:术中危象 56 例,术后危象 6 例(2 例兼有两种危象)。我们发现,术前无糖皮质激素治疗(比值比[OR]3.48;95%置信区间[CI]1.19-10.12)、术前 SBP 较高(每 10mmHg 增加 1.22,95%CI 1.03-1.45)、肿瘤较大(每增加 10mm 增加 1.09,95%CI 1.00-1.19)和无口服钠补充(OR 2.59,95%CI 1.25-5.35)是术中高血压危象的危险因素。发生高血压危象的患者术中出血量(P<0.001)、术中血流动力学不稳定(P<0.001)和术中低血压发作(P<0.001)的发生率均高于未发生高血压危象的患者。
PPGL 切除术中高血压危象的发生率高达 20%。术前未接受糖皮质激素治疗、肿瘤较大、术前 SBP 较高且未接受口服钠补充的患者,在 PPGL 手术期间和之后发生高血压危象的风险较高。